![Animation of two quotes.](/sites/default/files/2023-10/FNL-21155501-EN-VSX-CAROUSEL-ANIM-101023a.gif)
Addressing real-world challenges in AV Access
AV access maintenance solutions
The GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface* has proven success in the most challenging AV access cases, including early PTA failures, lesions at points of flexion, and in thrombosed grafts.
![IMAGE OF VSX PRODUCT](/sites/default/files/styles/max_750x750/public/2021-08/AZ0854-EN1-VSX-5409-FNL-OL-Large-cut.jpg.webp?itok=j2lx27lB)
![40% fewer reinterventions of thrombosed grafts demonstrated versus PTA through 2 years.5 / ca. 50% higher primary patency at 6 months than PTA alone.6](/sites/default/files/styles/max_750x750/public/2021-08/21155501-EN-VSX-Web-11-REV.jpg.webp?itok=88FxLa6n)
- Mohr BA, Sheen AL, Roy-Chaudhury P, Schultz SR, Aruny JE; REVISE Investigators. Clinical and economic benefits of stent grafts in dysfunctional and thrombosed hemodialysis access graft circuits in the REVISE Randomized Trial. Journal of Vascular & Interventional Radiology 2019;30(2):203-211.e4. https://www.jvir.org/article/S1051-0443(18)31772-X/fulltext
- Vesely T, DaVanzo W, Behrend T, Dwyer A, Aruny J. Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts. Journal of Vascular Surgery 2016;64(5):1400-1410.e1. http://www.sciencedirect.com/science/article/pii/S0741521416301756